These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 29343610

  • 21. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
    Li R, Xu X, Chen C, Wang Y, Gruzdev A, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2015 Feb 15; 308(4):E270-82. PubMed ID: 25389363
    [Abstract] [Full Text] [Related]

  • 22. CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes.
    Evangelista EA, Aliwarga T, Sotoodehnia N, Jensen PN, McKnight B, Lemaitre RN, Totah RA, Gharib SA.
    Sci Rep; 2020 Mar 24; 10(1):5329. PubMed ID: 32210298
    [Abstract] [Full Text] [Related]

  • 23. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis.
    Zhou C, Huang J, Li Q, Zhan C, Xu X, Zhang X, Ai D, Zhu Y, Wen Z, Wang DW.
    Free Radic Biol Med; 2018 Mar 24; 117():168-179. PubMed ID: 29427791
    [Abstract] [Full Text] [Related]

  • 24. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 25. Heat stress induces ferroptosis of porcine Sertoli cells by enhancing CYP2C9-Ras- JNK axis.
    Yang H, Cai X, Qiu M, Deng C, Xue H, Zhang J, Yang W, XianZhong W.
    Theriogenology; 2024 Feb 15; 215():281-289. PubMed ID: 38103405
    [Abstract] [Full Text] [Related]

  • 26. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
    Leow JWH, Verma RK, Lim ABH, Fan H, Chan ECY.
    Eur J Pharm Sci; 2021 Sep 01; 164():105889. PubMed ID: 34044117
    [Abstract] [Full Text] [Related]

  • 27. EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells.
    Feng W, Xu X, Zhao G, Li G, Liu T, Zhao J, Dong R, Wang DW, Tu L.
    Int J Mol Med; 2013 Sep 01; 32(3):685-93. PubMed ID: 23835530
    [Abstract] [Full Text] [Related]

  • 28. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
    Chen C, Wei X, Rao X, Wu J, Yang S, Chen F, Ma D, Zhou J, Dackor RT, Zeldin DC, Wang DW.
    J Pharmacol Exp Ther; 2011 Feb 01; 336(2):344-55. PubMed ID: 21030485
    [Abstract] [Full Text] [Related]

  • 29. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 30. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
    Chen W, Yang S, Ping W, Fu X, Xu Q, Wang J.
    Cell Physiol Biochem; 2015 Jul 18; 35(5):2043-54. PubMed ID: 25870948
    [Abstract] [Full Text] [Related]

  • 31. CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
    Zhou C, Huang J, Chen J, Lai J, Zhu F, Xu X, Wang DW.
    Cell Physiol Biochem; 2016 Jul 18; 39(2):721-39. PubMed ID: 27459385
    [Abstract] [Full Text] [Related]

  • 32. CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE-/- Mice.
    Liu W, Wang T, He X, Liu X, Wang B, Liu Y, Li Z, Tan R, Ding C, Wang H, Zeng H.
    J Cardiovasc Pharmacol; 2016 Jun 18; 67(6):491-502. PubMed ID: 26859195
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of Cytochrome P450 2J2-Mediated Metabolism of Rivaroxaban and Arachidonic Acid by Ibrutinib and Osimertinib.
    Wang Z, Yong Chan EC.
    Drug Metab Dispos; 2022 Oct 18; 50(10):1332-1341. PubMed ID: 35817438
    [Abstract] [Full Text] [Related]

  • 34. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
    Aliwarga T, Raccor BS, Lemaitre RN, Sotoodehnia N, Gharib SA, Xu L, Totah RA.
    Free Radic Biol Med; 2017 Nov 18; 112():131-140. PubMed ID: 28734877
    [Abstract] [Full Text] [Related]

  • 35. Anthracycline derivatives inhibit cardiac CYP2J2.
    Kim JS, Arango AS, Shah S, Arnold WR, Tajkhorshid E, Das A.
    J Inorg Biochem; 2022 Apr 18; 229():111722. PubMed ID: 35078036
    [Abstract] [Full Text] [Related]

  • 36. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.
    Leow JWH, Chan ECY.
    Pharmacol Ther; 2024 Jun 18; 258():108637. PubMed ID: 38521247
    [Abstract] [Full Text] [Related]

  • 37. Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2.
    Lee AC, Murray M.
    Mol Pharmacol; 2010 Jun 18; 77(6):987-94. PubMed ID: 20194533
    [Abstract] [Full Text] [Related]

  • 38. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.
    Circulation; 2004 Oct 12; 110(15):2132-6. PubMed ID: 15466638
    [Abstract] [Full Text] [Related]

  • 39. [Research progress of human cytochrome P450 2J2 and its ligands].
    Ma HY, Ning J, Ge GB, Yang L, Hao DC.
    Yao Xue Xue Bao; 2017 Jan 12; 52(1):26-33. PubMed ID: 29911373
    [Abstract] [Full Text] [Related]

  • 40. Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities.
    Kojima A, Nadai M, Murayama N, Yamazaki H, Katoh M.
    Xenobiotica; 2024 Sep 12; 54(9):642-647. PubMed ID: 39105612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.